The TGA is warning cardiologists that treating patients with the Absorb Bioresorbable Vascular Scaffold (BVS, Abbott Vascular) may increase the risk of major adverse cardiac events. In a safety alert issued late Monday the regulator said the stent was associated with greater rates of cardiac death, heart attack, and the need for an additional procedure ...
TGA issues warning on absorbable stent
By Sunalie Silva
30 Mar 2017